40842_2018_59_MOESM2_ESM.docx (35.02 kB)
Additional file 2: of Characteristics of insulin-Naïve people with type 2 diabetes who successfully respond to insulin glargine U100 after 24 weeks of treatment: a meta-analysis of individual participant data from 3 randomized clinical trials
journal contribution
posted on 2018-05-08, 05:00 authored by M. Cummings, D. Cao, I. Hadjiyianni, L. Ilag, M. TanTable S2. Outcomes of responders and nonresponders to IGlar at 24 weeks by study. Data are HbA1c, insulin dose, and FBG change from baseline to 24 weeks categorized by response (i.e., responders and nonresponders) in each study. (DOCX 35 kb)